enzh-TWfrdeitjaptrues
You are here: Home Publications Pub-2005 Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia

Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia


Can't see this document? Click Here

Legal | Privacy

Copyright © Bing Center for Waldenstrom's Macroglobulinemia 2000 - 2021